Renalytix Investor Relations Material
Latest events
Q2 2025
Renalytix
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Renalytix Plc
Access all reports
Renalytix Plc is a diagnostics company specializing in the development of tests that assess kidney health. The company integrates machine learning and clinical data to create predictive diagnostics aimed at improving kidney disease treatment. It serves healthcare providers and institutions through strategic collaborations and commercialization efforts. Renalytix Plc is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
RENX
Country
🇬🇧 United Kingdom